VIVUS LLC, a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with serious unmet medical needs, ...
A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising results in a first in-human phase 1/2 trial. The TACTOPS trial, which ...
Ongoing clinical research at UNC could lead to a first-of-its-kind enzyme replacement therapy for Hunter syndrome, an ultra-rare disorder that causes progressive multisystem disease and neurologic ...
Marissa Sulek joined CBS News Chicago in January 2025. Before Chicago, Marissa was a general assignment reporter in Nashville at WSMV, where she was nominated for Mid-South Emmy Awards for her ...
Share on Pinterest An FDA panel has called for an easing of restrictions on testosterone replacement therapy (TRT). Image Credit: Malorny/Getty Images A Food and Drug Administration (FDA) expert panel ...
Dawn Dean used to go down the aisle of supplements at the drugstore, looking for the answer to her hot flashes, night sweats and increasingly foggy brain. It was only when she turned to her ...
Scientists at UCLA have developed an "off-the-shelf" cell-based immunotherapy that was able to track down and kill pancreatic cancer cells even after they had spread to other organs. In a mouse study, ...
Autonomix's targeted ablation therapy improved symptoms, functionality, and quality of life in severe pancreatic cancer patients, especially those with stage 4 disease. Rapid pain relief and durable ...
Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced Monday the black box warning on women’s estrogen-based products for hormone replacement therapy (HRT) will be removed. “For ...
Experimental, drug-free, MRI-guided cancer treatment may one day offer a way of targeting and destroying pancreatic tumors without surgery or chemotherapy. (Nanowerk News) A new study has found for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results